By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT For the total 12 months 2023, complete revenues elevated roughly 5.0% to $36.3 million. Complete product gross sales had been $31.1 million, a rise of 6.0% from 2022. 2022 gross sales benefitted from $0.7 million in different non-CytoSorb gross sales and $0.3 million in … Read more
By M. Marin NYSE:AMS READ THE FULL AMS RESEARCH REPORT Momentum accelerating, with Rhode Island most cancers facilities, plus new Linear Accelerator in Mexico representing new income sources… Based in 1983, American Shared Hospital Providers (NYSE:AMS), which supplies stereotactic radiosurgery gear and superior radiation remedy remedy methods to deal with most cancers sufferers, reported 2023 … Read more
By Thomas Kerr, CFA NASDAQ:HTCR READ THE FULL HTCR RESEARCH REPORT On April 1, 2024, HeartCore Enterprises (NASDAQ:HTCR) introduced it had licensed a dividend fee within the quantity of $0.02 per share which can whole $417,283 to be paid by the corporate. After evaluating the Firm’s steadiness sheet and monetary profile, HeartCore and its Board … Read more
By Brian Lantier, CFA NASDAQ:SVRE READ THE FULL SVRE RESEARCH REPORT SaverOne 2014 (NASDAQ:SVRE) introduced the long-anticipated OEM settlement with IVECO that was first mentioned in 2022 when the businesses signed a memorandum of understanding. The settlement covers the mixing of SaverOne’s “security expertise” inside IVECO’s automobiles. As a reminder, whereas the corporate will not … Read more
Chief Science Officer, Dr. Mark Rains. Picture courtesy of Tyler Jones (UF/IFAS). Dr. Rains harassed the significance of comprehending the adjustments in Florida’s water provide and high quality over the previous decade, urging collaboration throughout disciplines for impactful options. UF’s intensive vary of disciplines, excellent college students and college, and strategically positioned Extension brokers throughout … Read more
